Figure 1From: Impact of oral anti–hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolizationKaplan-Meier curves of overall survival for 224 hepatocellular carcinoma (HCC) patients with or without antiviral treatment. Survival rate in the antiviral treatment group was significantly higher than that in the non-antiviral treatment group. TACE, transarterial chemoembolization; CI, confidence interval.Back to article page